Can a simple injection ease Post-Birth pain?
NCT ID NCT03084549
First seen Nov 17, 2025 · Last updated Jun 23, 2026 · Updated 34 times
Summary
This study tested whether injecting the anesthetic ropivacaine into the area of an episiotomy (a cut made during childbirth) reduces pain better than a placebo. 272 women who had an episiotomy during delivery took part. The goal was to see if this simple treatment could improve comfort in the days and weeks after birth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPISIOTOMY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Departemental Vendee
La Roche-sur-Yon, 85925, France
-
Centre Hospitalier Universitaire Nantes
Nantes, 44093, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ropivacaine (a local anesthetic)
What this could lead to
If it works, this could provide a simple, well-tolerated way to reduce pain after an episiotomy, potentially improving recovery for many women.
What could go wrong
This is a completed phase 3 trial, so results are available. However, the benefit may be modest or short-lived, and not all women may experience significant pain relief.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.